Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

113 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Multicentre cohort study evaluating clinical, oncological and functional outcomes following robotic rectal cancer surgery-the EUREKA collaborative: trial protocol.
Fleming CA, Duhoky R, Geitenbeek RTJ, Moussion A, Bouazza N, Khan J, Cotte E, Dubois A, Rullier E, Hompes R, Denost Q, Rouanet P, Consten ECJ; EUREKA collaborative. Fleming CA, et al. Among authors: bouazza n. BJS Open. 2024 Mar 1;8(2):zrae019. doi: 10.1093/bjsopen/zrae019. BJS Open. 2024. PMID: 38578718 Free PMC article. No abstract available.
Rectal Surgery Evaluation Trial: protocol for a parallel cohort trial of outcomes using surgical techniques for total mesorectal excision with low anterior resection in high-risk rectal cancer patients.
Rouanet P, Gourgou S, Gogenur I, Jayne D, Ulrich A, Rautio T, Spinoglio G, Bouazza N, Moussion A, Gomez Ruiz M. Rouanet P, et al. Among authors: bouazza n. Colorectal Dis. 2019 May;21(5):516-522. doi: 10.1111/codi.14581. Epub 2019 Mar 14. Colorectal Dis. 2019. PMID: 30740878
MESOTIP: Phase II multicenter randomized trial evaluating the association of PIPAC and systemic chemotherapy vs. systemic chemotherapy alone as 1st-line treatment of malignant peritoneal mesothelioma.
Sgarbura O, Gourgou S, Tosi D, Bakrin N, Bouazza N, Delaine S, De Forges H, Pocard M, Quénet F. Sgarbura O, et al. Among authors: bouazza n. Pleura Peritoneum. 2019 Jun 27;4(2):20190010. doi: 10.1515/pp-2019-0010. eCollection 2019 Jun 1. Pleura Peritoneum. 2019. PMID: 31417958 Free PMC article.
COBRAPed cohort: Do sensitization patterns differentiate children with severe asthma from those with a milder disease?
Lejeune S, Bouazza N, Nicaise PR, Jolaine V, Roditis L, Marguet C, Amat F, Berger P, Fayon M, Dubus JC, Valois S, Reix P, Pellan M, Brouard J, Chiron R, Giovannini-Chami L, de Blic J, Deschildre A, Lezmi G; COBRAPed Study Group. Lejeune S, et al. Among authors: bouazza n. Pediatr Allergy Immunol. 2024 Mar;35(3):e14112. doi: 10.1111/pai.14112. Pediatr Allergy Immunol. 2024. PMID: 38520021
Lumacaftor/Ivacaftor Population Pharmacokinetics in Pediatric Patients with Cystic Fibrosis: A First Step Toward Personalized Therapy.
Bouazza N, Urien S, Foissac F, Choupeaux L, Lui G, Froelicher Bournaud L, Rouillon S, Zheng Y, Bardin E, Stremler N, Bessaci K, Bihouee T, Coirier-Duet E, Marguet C, Deneuville E, Laurans M, Reix P, Gerardin M, Mittaine M, Epaud R, Thumerelle C, Weiss L, Berthaud R, Semeraro M, Treluyer JM, Benaboud S, Sermet-Gaudelus I. Bouazza N, et al. Clin Pharmacokinet. 2024 Mar;63(3):333-342. doi: 10.1007/s40262-023-01342-3. Epub 2024 Feb 4. Clin Pharmacokinet. 2024. PMID: 38310629
Prophylactic Intravenous Acetaminophen in Extremely Premature Infants: Minimum Effective Dose Research by Bayesian Approach.
Bouazza N, Cambonie G, Flamant C, Rideau A, Tauzin M, Patkai J, Gascoin G, Lumia M, Aikio O, Lui G, Bournaud LF, Walsh-Papageorgiou A, Tortigue M, Baruteau AE, Kallio J, Hallman M, Diallo A, Levoyer L, Treluyer JM, Roze JC. Bouazza N, et al. Paediatr Drugs. 2024 Jan;26(1):83-93. doi: 10.1007/s40272-023-00602-w. Epub 2023 Nov 17. Paediatr Drugs. 2024. PMID: 37978159 Free PMC article. Clinical Trial.
The experience of diagnosis announcement in rare endocrine diseases: A survey of the French FIRENDO network.
Rahabi H, Givony M, Demaret B, Albarel F, Aubron MR, Bartès B, Bernard L, Abdoul H, Bouazza N, Brun P, Drui D, Dujardin V, Lançon C, Malivoir S, Netchine I, Perrotin B, Picard V, Reynaud R, Ribeiro M, Tardy Guidollet V, Victor A, Bertherat J, Colin C, Brue T. Rahabi H, et al. Among authors: bouazza n. Ann Endocrinol (Paris). 2024 Feb;85(1):27-35. doi: 10.1016/j.ando.2023.10.008. Epub 2023 Nov 10. Ann Endocrinol (Paris). 2024. PMID: 37951412
Theratyping cystic fibrosis patients to guide elexacaftor/tezacaftor/ivacaftor out-of-label prescription.
Dreano E, Burgel PR, Hatton A, Bouazza N, Chevalier B, Macey J, Leroy S, Durieu I, Weiss L, Grenet D, Stremler N, Ohlmann C, Reix P, Porzio M, Roux Claude P, Rémus N, Douvry B, Montcouquiol S, Cosson L, Mankikian J, Languepin J, Houdouin V, Le Clainche L, Guillaumot A, Pouradier D, Tissot A, Priou P, Mély L, Chedevergne F, Lebourgeois M, Lebihan J, Martin C, Zavala F, Da Silva J, Lemonnier L, Kelly-Aubert M, Golec A, Foucaud P, Marguet C, Edelman A, Hinzpeter A, de Carli P, Girodon E, Sermet-Gaudelus I, Pranke I; French CF Reference Network study group. Dreano E, et al. Among authors: bouazza n. Eur Respir J. 2023 Oct 19;62(4):2300110. doi: 10.1183/13993003.00110-2023. Print 2023 Oct. Eur Respir J. 2023. PMID: 37696564
113 results